Compare NetEase Inc (NTES) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

NetEase (NTES) trades at $129.57, down 1.31% over the past day, with a bullish technical outlook supported by moving averages. The company reported strong Q1 2026 earnings of $2.53 EPS, beating expectations, and maintains robust profitability with a 29.84% net income margin. Recent news highlights international expansion and a Zacks Strong Buy upgrade, while the stock offers a dividend with the next payment scheduled for June 18, 2026.

The outlook for NTES is positive, driven by earnings growth, cash flow strength, and analyst optimism, with a 34.66% upside to price targets. Key risks include China market volatility and competitive pressures in gaming. The stock presents a value opportunity with a P/E of 17.26, but investors should monitor geopolitical and regulatory developments.

Dentsply Sirona (XRAY) trades at $13.65, down 2.91% on the day, with a mixed technical picture showing a bullish moving average signal but overbought RSI levels. Fundamentally, the company reported a net loss of $598 million for 2025, with negative profit margins and an elevated EV/EBITDA of 91.48, though revenue remains stable near $3.7 billion. Recent news includes the appointment of a new CFO and expanded U.S. distribution partnerships, while the upcoming Q2 2026 earnings call on August 6 is a key near-term catalyst.

The outlook remains challenging due to persistent losses and margin pressure, offset by strategic growth initiatives. Investment opportunities lie in the company's market leadership and digital dentistry expansion, but risks include high debt levels, competitive pressures, and the need for a successful turnaround. Analyst consensus is Hold with a price target of $13.33, indicating limited near-term upside from current levels.